{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig2rjbz7d4lhuky7ljmrvjtae5wcccmgjp4h53gzrkppxpih3ix6e",
    "uri": "at://did:plc:tpd4fxsnyhzzhnj6g4llqsfn/app.bsky.feed.post/3mnfideqygzv2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidn6pf5ytykvjlbpq4q7dbfzk5qtw6dp52xllc7bvpov3k3nz4goy"
    },
    "mimeType": "image/jpeg",
    "size": 31242
  },
  "path": "/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/",
  "publishedAt": "2026-06-03T14:04:42.000Z",
  "site": "https://globalnews.ca",
  "tags": [
    "Canada",
    "Health",
    "Pancreatic Cancer",
    "Princess Margaret Cancer Centre"
  ],
  "textContent": "Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results \"amazing.\"",
  "title": "Pancreatic cancer pill that doubled survival may get Canada clinical trial"
}